Can routinely collected administrative data effectively be used to evaluate and validate endpoints used in breast cancer clinical trials? Protocol for a scoping review of the literature
© 2023. The Author(s)..
BACKGROUND: Randomized controlled trials (RCTs) are a critical component of evidence-based medicine and the evolution of patient care. However, the costs of conducting a RCT can be prohibitive. A promising approach toward reduction of costs and lessening of the burden of intensive and lengthy patient follow-up is the use of routinely collected healthcare data (RCHD), commonly called real-world data. We propose a scoping review to identify existing RCHD case definitions of breast cancer progression and survival and their diagnostic performance.
METHODS: We will search MEDLINE, EMBASE, and CINAHL to identify primary studies of women with either early-stage or metastatic breast cancer, managed with established therapies, that evaluated the diagnostic accuracy of one or more RCHD-based case definitions or algorithms of disease progression (i.e., recurrence, progression-free survival, disease-free survival, or invasive disease-free survival) or survival (i.e., breast-cancer-free survival or overall survival) compared with a reference standard measure (e.g., chart review or a clinical trial dataset). Study characteristics and descriptions of algorithms will be extracted along with measures of the diagnostic accuracy of each algorithm (e.g., sensitivity, specificity, positive predictive value, negative predictive value), which will be summarized both descriptively and in structured figures/tables.
DISCUSSION: Findings from this scoping review will be clinically meaningful for breast cancer researchers globally. Identification of feasible and accurate strategies to measure patient-important outcomes will potentially reduce RCT budgets as well as lessen the burden of intensive trial follow-up on patients.
SYSTEMATIC REVIEW REGISTRATION: Open Science Framework ( https://doi.org/10.17605/OSF.IO/6D9RS ).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Systematic reviews - 12(2023), 1 vom: 08. Juli, Seite 117 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shah, Hely [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Administrative data |
|---|
| Anmerkungen: |
Date Completed 12.07.2023 Date Revised 06.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13643-023-02283-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35923707X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35923707X | ||
| 003 | DE-627 | ||
| 005 | 20240206231853.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13643-023-02283-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1282.xml |
| 035 | |a (DE-627)NLM35923707X | ||
| 035 | |a (NLM)37422656 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shah, Hely |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Can routinely collected administrative data effectively be used to evaluate and validate endpoints used in breast cancer clinical trials? Protocol for a scoping review of the literature |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.07.2023 | ||
| 500 | |a Date Revised 06.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a BACKGROUND: Randomized controlled trials (RCTs) are a critical component of evidence-based medicine and the evolution of patient care. However, the costs of conducting a RCT can be prohibitive. A promising approach toward reduction of costs and lessening of the burden of intensive and lengthy patient follow-up is the use of routinely collected healthcare data (RCHD), commonly called real-world data. We propose a scoping review to identify existing RCHD case definitions of breast cancer progression and survival and their diagnostic performance | ||
| 520 | |a METHODS: We will search MEDLINE, EMBASE, and CINAHL to identify primary studies of women with either early-stage or metastatic breast cancer, managed with established therapies, that evaluated the diagnostic accuracy of one or more RCHD-based case definitions or algorithms of disease progression (i.e., recurrence, progression-free survival, disease-free survival, or invasive disease-free survival) or survival (i.e., breast-cancer-free survival or overall survival) compared with a reference standard measure (e.g., chart review or a clinical trial dataset). Study characteristics and descriptions of algorithms will be extracted along with measures of the diagnostic accuracy of each algorithm (e.g., sensitivity, specificity, positive predictive value, negative predictive value), which will be summarized both descriptively and in structured figures/tables | ||
| 520 | |a DISCUSSION: Findings from this scoping review will be clinically meaningful for breast cancer researchers globally. Identification of feasible and accurate strategies to measure patient-important outcomes will potentially reduce RCT budgets as well as lessen the burden of intensive trial follow-up on patients | ||
| 520 | |a SYSTEMATIC REVIEW REGISTRATION: Open Science Framework ( https://doi.org/10.17605/OSF.IO/6D9RS ) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Administrative data | |
| 650 | 4 | |a Breast cancer | |
| 650 | 4 | |a Real-world data | |
| 650 | 4 | |a Recurrence | |
| 650 | 4 | |a Scoping review | |
| 700 | 1 | |a Wolfe, Dianna |e verfasserin |4 aut | |
| 700 | 1 | |a Clemons, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Michelle |e verfasserin |4 aut | |
| 700 | 1 | |a Thavorn, Kednapa |e verfasserin |4 aut | |
| 700 | 1 | |a Veroniki, Areti-Angeliki |e verfasserin |4 aut | |
| 700 | 1 | |a Lunny, Carole |e verfasserin |4 aut | |
| 700 | 1 | |a Pond, Greg |e verfasserin |4 aut | |
| 700 | 1 | |a McGee, Sharon |e verfasserin |4 aut | |
| 700 | 1 | |a Skidmore, Becky |e verfasserin |4 aut | |
| 700 | 1 | |a Arnaout, Angel |e verfasserin |4 aut | |
| 700 | 1 | |a Hutton, Brian |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Systematic reviews |d 2012 |g 12(2023), 1 vom: 08. Juli, Seite 117 |w (DE-627)NLM217806902 |x 2046-4053 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:1 |g day:08 |g month:07 |g pages:117 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13643-023-02283-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 1 |b 08 |c 07 |h 117 | ||